Steroids Blog

As per a new study conducted by researchers from the Ohio State University Medical Center, a substance created by body’s immune cells can play a critical role in progression of disease in animals, which closely mimics multiple sclerosis.

The study concluded that the molecule, known as macrophage migration inhibitory factor (MIF), can help in effectively preventing multiple sclerosis.

From News-Medical.Net:

“Our results suggest that MIF may be less important for initiating MS, but that it may be necessary for MS progression,” says principal investigator Caroline C. Whitacre, professor of molecular virology, immunology and medical genetics.

“These findings indicate that in the future we can perhaps use MIF levels to predict the onset of a relapse. But more importantly, perhaps this study will lead to drugs that can halt the course of MS by blocking the action of MIF.”

Though MIF may be regarded as not so important for the initiation of multiple sclerosis (MS), it is important for the progression of MS, as per principal investigator Caroline C. Whitacre, Professor of molecular virology, immunology and medical genetics.

These findings suggested that the MIF levels can be effectively used to predict the onset of a relapse. Moreover, this study is expected to create new paradigm for halting the course of MS by blockage of MIF activities.